Mrs Susie Roczo-Farkas

Research Assistant
Infection and Immunity Theme
Murdoch Childrens Research Institute

Other opportunities

The Australian Rotavirus Surveillance Program relies heavily on collaborating pathology laboratories and hospitals, which routinely test faecal specimens for rotavirus. We are continuously looking to expand this network, so that we could have greater access to rotavirus positive samples, thereby …
creating a better snapshot of rotavirus diversity and distribution in Australia. Our focus is on children under 5 years of age, hospitalised with acute gastroenteritis. However, we do not restrict age of patient for our cohort.

Our collaborators are asked to store rotavirus positive samples, which we then organise to have sent to our laboratory at the Murdoch Children's Research Institute, in Melbourne, Victoria. If you would like to help our group by sending rotavirus positive stool specimens, please contact us. Your help is much appreciated.



SEE MORE DETAIL |

Latest News

Australian Rotavirus Surveillance Program Annual Reports:
http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-pubs-annlrpt-rotavar.htm

Research Activities

Australian Rotavirus Surveillance Program
Enteric Virus Group – Murdoch Children’s Research Institute

Susie Roczo-Farkas coordinates the Australian Rotavirus Surveillance Program (ARSP), which conducts a nationwide study on the rotavirus types circulating in children around Australia. This program undertakes molecular epidemiological studies on the rotavirus strains prevalent in Australia, which allows us to track seasonal changes in rotavirus strains causing severe disease. In addition, the laboratory is also the WHO regional rotavirus reference laboratory and a WHO Collaborating Centre, and is involved with a range of molecular epidemiological studies to characterise the wildtype rotavirus strain population in several countries throughout the Western Pacific Region.

The introduction and implementation of the national rotavirus vaccine program across Australia will increase the selective pressures on circulating wildtype strains, and may result in the emergence of new rotavirus strains. If this happens, these strains will likely impact vaccination programs. Understanding how vaccine introduction has impacted the circulating rotavirus population by altering the prevalence of common genotypes, selection of antigenic variants and emergence of new or novel types causing disease is the focus of the group’s research. The genetic and biological mechanisms underlying vaccine escape will be studied, providing critical information about the circulating rotavirus population that will help maintain a successful ongoing rotavirus vaccine program. The ARSP have published surveillance data as annual reports in CDI since 1999.



Techniques/Expertise

  • Epidemiology
  • Rotavirus National Surveillance
  • Molecular techniques, primarily RT-PCR and Sanger sequencing for genotyping

Other members with similar research interests

prev next

Dr Christopher Morgan

Centre for International Health Burnet Institute SEE FULL PROFILE >

Emeritus Professor Gregory Tannock

Centre for Biomedical Research Burnet Institute SEE FULL PROFILE >

A/Prof Kumar Visvanathan

University of Melbourne SEE FULL PROFILE >

Upcoming Events

  • Feb 14

    Lorne Infection and Immunity Conference 2018

    Cumberland Lorne Resort REGISTER | MORE INFO
  • Mar 1

    18th International Congress on Infectious Diseases

    Sheraton Buenos Aires MORE INFO
  • Mar 15

    Eradicate Cancer 2018

    Melbourne Convention and Exhibition Centre MORE INFO